FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323539009> ?p ?o ?g. }

• W4323539009 abstract "Although viral hepatocellular carcinoma (HCC) is declining, non-viral HCC, which often is the end-stage of non-alcoholic or alcoholic steatohepatitis (NASH, ASH), is on an upward trajectory. Immune checkpoint inhibitors (ICI) that block the T cell inhibitory receptor PD-1 were approved for treatment of all HCC types. However, only a small portion of HCC patients show a robust and sustained response to PD-1 blockade, calling for improved understanding of factors that negatively impact response rate and duration and the discovery of new adjuvant treatments that enhance ICI responsiveness. Using a mouse model of NASH-driven HCC, we identified peritumoral fibrosis as a potential obstacle to T cell mediated tumor regression and postulated that anti-fibrotic medications may increase ICI responsiveness. We now show that the angiotensin II receptor inhibitor losartan, a commonly prescribed and safe antihypertensive drug, reduced liver and peritumoral fibrosis and substantially enhanced anti-PD-1 induced tumor regression. Although losartan did not potentiate T cell reinvigoration, it substantially enhanced HCC infiltration by effector CD8 + T cells compared to PD-1 blockade alone. The beneficial effects of losartan correlated with inhibition of TGF-β receptor signaling, collagen deposition and depletion of immunosuppressive fibroblasts.Immune checkpoint inhibitors are used in HCC treatment but overall response rates for single agent PD-1/PD-L1 blockers have remained stubbornly low. Using a mouse model of NASH-driven HCC, we show that co-treatment with the safe and inexpensive angiotensin II receptor inhibitor losartan substantially enhanced anti-PD-1 triggered HCC regression. Although losartan did not influence the reinvigoration of exhausted CD8 + T cells it considerably enhanced their intratumoral invasion, which we postulated to be compromised by peritumoral fibrosis. Indeed, the beneficial effect of losartan correlated with inhibition of TGF-β signaling and collagen deposition, and depletion of immunosuppressive fibroblasts. Losartan should be evaluated for its adjuvant activity in HCC patients undergoing PD-1/PD-L1 blocking therapy." @default.
• W4323539009 created "2023-03-09" @default.
• W4323539009 creator A5010902331 @default.
• W4323539009 creator A5014236405 @default.
• W4323539009 creator A5016441397 @default.
• W4323539009 creator A5031562282 @default.
• W4323539009 creator A5037690393 @default.
• W4323539009 creator A5044728854 @default.
• W4323539009 creator A5046065062 @default.
• W4323539009 creator A5052131680 @default.
• W4323539009 creator A5056315342 @default.
• W4323539009 creator A5067227071 @default.
• W4323539009 creator A5069833442 @default.
• W4323539009 creator A5077290507 @default.
• W4323539009 date "2023-03-06" @default.
• W4323539009 modified "2023-10-16" @default.
• W4323539009 title "Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells" @default.
• W4323539009 cites W128626585 @default.
• W4323539009 cites W1970136916 @default.
• W4323539009 cites W1995378042 @default.
• W4323539009 cites W2066576676 @default.
• W4323539009 cites W2085390667 @default.
• W4323539009 cites W2096064097 @default.
• W4323539009 cites W2098054841 @default.
• W4323539009 cites W2126232334 @default.
• W4323539009 cites W2131381643 @default.
• W4323539009 cites W2292383635 @default.
• W4323539009 cites W239124720 @default.
• W4323539009 cites W2606367731 @default.
• W4323539009 cites W2767554904 @default.
• W4323539009 cites W2785803176 @default.
• W4323539009 cites W2800261814 @default.
• W4323539009 cites W2805592007 @default.
• W4323539009 cites W2806476042 @default.
• W4323539009 cites W2885998663 @default.
• W4323539009 cites W2890335225 @default.
• W4323539009 cites W2890337997 @default.
• W4323539009 cites W2901814223 @default.
• W4323539009 cites W2909932177 @default.
• W4323539009 cites W2932470287 @default.
• W4323539009 cites W2938117765 @default.
• W4323539009 cites W2980538229 @default.
• W4323539009 cites W2986691533 @default.
• W4323539009 cites W2990602950 @default.
• W4323539009 cites W2999506325 @default.
• W4323539009 cites W3020974416 @default.
• W4323539009 cites W3024919611 @default.
• W4323539009 cites W3080672636 @default.
• W4323539009 cites W3107895035 @default.
• W4323539009 cites W3131620481 @default.
• W4323539009 cites W3138484572 @default.
• W4323539009 cites W3152534107 @default.
• W4323539009 cites W3179963300 @default.
• W4323539009 cites W3199671553 @default.
• W4323539009 cites W3202269819 @default.
• W4323539009 cites W3208498374 @default.
• W4323539009 cites W4210774372 @default.
• W4323539009 cites W4283368549 @default.
• W4323539009 cites W4293462113 @default.
• W4323539009 cites W4297338588 @default.
• W4323539009 cites W4307931717 @default.
• W4323539009 cites W4308891835 @default.
• W4323539009 cites W4309108396 @default.
• W4323539009 doi "https://doi.org/10.1101/2023.03.05.531188" @default.
• W4323539009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36945365" @default.
• W4323539009 hasPublicationYear "2023" @default.
• W4323539009 type Work @default.
• W4323539009 citedByCount "0" @default.
• W4323539009 crossrefType "posted-content" @default.
• W4323539009 hasAuthorship W4323539009A5010902331 @default.
• W4323539009 hasAuthorship W4323539009A5014236405 @default.
• W4323539009 hasAuthorship W4323539009A5016441397 @default.
• W4323539009 hasAuthorship W4323539009A5031562282 @default.
• W4323539009 hasAuthorship W4323539009A5037690393 @default.
• W4323539009 hasAuthorship W4323539009A5044728854 @default.
• W4323539009 hasAuthorship W4323539009A5046065062 @default.
• W4323539009 hasAuthorship W4323539009A5052131680 @default.
• W4323539009 hasAuthorship W4323539009A5056315342 @default.
• W4323539009 hasAuthorship W4323539009A5067227071 @default.
• W4323539009 hasAuthorship W4323539009A5069833442 @default.
• W4323539009 hasAuthorship W4323539009A5077290507 @default.
• W4323539009 hasBestOaLocation W43235390091 @default.
• W4323539009 hasConcept C126322002 @default.
• W4323539009 hasConcept C134018914 @default.
• W4323539009 hasConcept C170493617 @default.
• W4323539009 hasConcept C2778019345 @default.
• W4323539009 hasConcept C2780288358 @default.
• W4323539009 hasConcept C2780559512 @default.
• W4323539009 hasConcept C2908929049 @default.
• W4323539009 hasConcept C502942594 @default.
• W4323539009 hasConcept C71924100 @default.
• W4323539009 hasConcept C98274493 @default.
• W4323539009 hasConceptScore W4323539009C126322002 @default.
• W4323539009 hasConceptScore W4323539009C134018914 @default.
• W4323539009 hasConceptScore W4323539009C170493617 @default.
• W4323539009 hasConceptScore W4323539009C2778019345 @default.
• W4323539009 hasConceptScore W4323539009C2780288358 @default.
• W4323539009 hasConceptScore W4323539009C2780559512 @default.
• W4323539009 hasConceptScore W4323539009C2908929049 @default.
• W4323539009 hasConceptScore W4323539009C502942594 @default.

• next